The activation of human blood coagulation factor X on the surface of endothelial cells: a comparison with various vascular cells, platelets and monocytes
- 1 June 1994
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 87 (2) , 332-342
- https://doi.org/10.1111/j.1365-2141.1994.tb04918.x
Abstract
Rates of factor X activation on endothelial cells were compared with activation rates on other vascular cells, platelets, monocytes and negatively charged phospholipid vesicles. Factor VIIa-mediated factor X activation was observed on smooth muscle cells and fibroblasts in the absence of cell-perturbing agents, whereas endothelial cells required activation in order to allow extrinsic activation of factor X. On the other hand, unperturbed endothelial cells did promote intrinsic, factor VIII/IXa-dependent activation of factor X. The rate of factor X activation on these cells was about one-sixth of that on ionophore A23187-stimulated platelets. Also, smooth muscle cells and fibroblasts were able to activate factor X through the intrinsic pathway, although to a lesser extent than endothelial cells. Monocytes were ineffective in this respect. Prothrombin fragment 1, the prothrombin fragment containing the gamma-carboxyglutamic acid domain known to mediate binding of vitamin K-dependent coagulation factors to phospholipid surfaces, inhibited factor VIII/IXa-dependent factor X activation on endothelial cells (IC50 3.2 microM) to a lesser extent than on phospholipid vesicles (IC50 0.2 microM). Therefore, besides negatively charged phospholipids, other membrane constituents seem to be involved in endothelial cell mediated, intrinsic activation of factor X. Perturbation of endothelial cells with phorbol myristate acetate (PMA) or lipopolysaccharide (LPS) was without effect on intrinsic activation of factor X. This observation indicates that membrane constituents of endothelial cells involved in factor VIII/IXa-dependent activation of factor X are constitutively expressed.Keywords
This publication has 34 references indexed in Scilit:
- Identification of connective tissue gene transcripts in freshly isolated parenchymal, endothelial, Kupffer and fat-storing cells by Northern hybridization analysisJournal of Hepatology, 1993
- Expression of cytoadhesion molecules (CD56, CD54, CD18 and CD29) by myeloma plasma cellsBritish Journal of Haematology, 1991
- High Plasma Fibronectin Levels in Multiple Myeloma Patients: Possible Mechanisms and Clinical ImplicationsScandinavian Journal of Immunology, 1991
- Characterization of a new IgGλ myeloma plasma cell line (EJM): a further tool in the investigation of the biology of multiple myelomaBritish Journal of Haematology, 1990
- Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.Journal of Clinical Investigation, 1989
- Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.The Journal of Experimental Medicine, 1989
- FIBRONECTIN AND ITS RECEPTORSAnnual Review of Biochemistry, 1988
- Two distinct human myeloma cell lines originating from one patient with myelomaInternational Journal of Cancer, 1985
- Three different fibronectin mRNAs arise by alternative splicing within the coding regionCell, 1983
- Characteristics of established myeloma and lymphoblastoid cell lines derived from an e myeloma patient: A comparative studyInternational Journal of Cancer, 1971